Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-004833-25Phase 4Active
Phase 4, open-label, single-arm trial of propofol and remifentanil, sponsored by Parc de Salut Mar. Primary endpoint: Functional magnetic resonance imaging changes. Started Jan 2017; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-004833-25.